Fast, long-term relief from opioid dependence?
By
This week, the FDA could approve Braeburn Pharmaceuticals' buprenorphine implant, which provides up to six months continuous treatment for the withdrawal symptoms and cravings of opioid dependence.
Real-time updates and all local stories you want right in the palm of your hand.
